Evolving role of immunotherapy in head-and-neck cancers: A systemic review

Evolving role of immunotherapy in head-and-neck cancers: A systemic review

Head-and-neck squamous cell cancers (HNSCCs) are one of the most common cancers worldwide and account for more than half million new cases and 380,000 deaths per year. A large number of patients are diagnosed with locally advanced disease and require multimodal treatment approaches. Despite advances...

Full description

Bibliographic Details
Main Authors: Raajit Chanana, Vanita Noronha, Amit Joshi, Vijay Patil, Kumar Prabhash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Journal of Head & Neck Physicians and Surgeons
Subjects:
Head-and-neck cancers
immunology
immunotherapy
nivolumab
pembrolizumab
Online Access:http://www.jhnps.org/article.asp?issn=2347-8128;year=2018;volume=6;issue=1;spage=2;epage=11;aulast=Chanana

Internet

http://www.jhnps.org/article.asp?issn=2347-8128;year=2018;volume=6;issue=1;spage=2;epage=11;aulast=Chanana

Similar Items